160 related articles for article (PubMed ID: 1969685)
1. [Hemodynamic and humoral changes following intravenous administration of xamoterol in patients with heart failure and coronary heart disease].
Erlemeier HH; Kupper W; Bleifeld W
Z Kardiol; 1990 Feb; 79(2):126-33. PubMed ID: 1969685
[TBL] [Abstract][Full Text] [Related]
2. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
Virk SJ; Davies MK
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
[TBL] [Abstract][Full Text] [Related]
3. Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol.
Erlemeier HH; Kupper W; Bleifeld W
Cardiology; 1990; 77(1):30-9. PubMed ID: 1972349
[TBL] [Abstract][Full Text] [Related]
4. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H
Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823
[TBL] [Abstract][Full Text] [Related]
5. [Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
Richaud M; Lechat P; Komajda M; Landault C; Fournier P; Fraysse JB; Grosgogeat Y
Arch Mal Coeur Vaiss; 1990 Feb; 83(2):247-52. PubMed ID: 1968739
[TBL] [Abstract][Full Text] [Related]
6. Xamoterol in patients with dilated cardiomyopathy: an increase in beta-receptors in lymphocytes.
Watanabe K; Hirokawa Y; Shibata A
J Cardiol; 1988 Dec; 18(4):1015-25. PubMed ID: 2908309
[TBL] [Abstract][Full Text] [Related]
7. Exercise capacity, arrhythmias, humoral and chemical parameters during long-term therapy with xamoterol.
Erlemeier HH; Kupper W; Bleifeld W
Int J Cardiol; 1990 Aug; 28(2):197-208. PubMed ID: 1697569
[TBL] [Abstract][Full Text] [Related]
8. [The value of xamoterol in moderate ischemic cardiac insufficiency].
Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F
Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
[TBL] [Abstract][Full Text] [Related]
9. Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial.
de Feyter PJ; Serruys PW; Suryapranata H
Circulation; 1990 Feb; 81(2 Suppl):III99-106. PubMed ID: 1967562
[TBL] [Abstract][Full Text] [Related]
10. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
[TBL] [Abstract][Full Text] [Related]
11. Effects of the beta 1-adrenergic receptor partial agonist xamoterol on left ventricular diastolic function. An evaluation after 1-6 years of oral therapy.
Pouleur H; Etienne J; Van Mechelen H; Gurné O; Rousseau MF
Circulation; 1990 Feb; 81(2 Suppl):III87-92. PubMed ID: 1967560
[TBL] [Abstract][Full Text] [Related]
12. The acute effects of intravenous xamoterol ('Corwin', I.C.I. 118, 587) on resting and exercise haemodynamics in patients with mild to moderate heart failure.
Virk SJ; Anfilogoff NH; Lawson N; Sadler AM; Smith SJ; Nuttall A; Murray RG; Littler WA; Davies MK
Eur Heart J; 1989 Mar; 10(3):227-34. PubMed ID: 2565233
[TBL] [Abstract][Full Text] [Related]
13. [Hemodynamic effects at rest and exertion of a new partial beta-agonist (cicloprolol) in moderated cardiac failure].
Rigaud M; Hamoir V; Chabanier A; Neveux E; Cazor JL; Bardet J; Bourdarias JP
Arch Mal Coeur Vaiss; 1988 Oct; 81(10):1251-8. PubMed ID: 2906233
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and neurohumoral effects of ketanserin, a 5-HT2 receptor antagonist in patients with congestive heart failure.
Majid PA; Morris WM; Sole MJ
Can J Cardiol; 1987 Mar; 3(2):70-4. PubMed ID: 3567710
[TBL] [Abstract][Full Text] [Related]
15. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
[TBL] [Abstract][Full Text] [Related]
17. [Anti-ischemia effects of gallopamil and esmolol in an intra-individual comparison in patients with coronary heart disease].
Mitrovic V; Oehm E; Minge C; Thürmann P; Schlepper M
Z Kardiol; 1994 Jun; 83(6):431-8. PubMed ID: 7915067
[TBL] [Abstract][Full Text] [Related]
18. Relation of diastolic function and exercise capacity in ischemic left ventricular dysfunction. Role of beta-agonists and beta-antagonists.
Pouleur H; Hanet C; Rousseau MF; van Eyll C
Circulation; 1990 Aug; 82(2 Suppl):I89-96. PubMed ID: 1973644
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol in relation to plasma norepinephrine levels during exercise in patients with left ventricular dysfunction.
Sato H; Inoue M; Matsuyama T; Ozaki H; Shimazu T; Takeda H; Ishida Y; Kamada T
Circulation; 1987 Jan; 75(1):213-20. PubMed ID: 2878742
[TBL] [Abstract][Full Text] [Related]
20. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
